Daliresp
Product intended to target chronic obstructive pulmonary disease and formulated to alleviate respiratory inflammation.
- Category
- Respiratory Health
- Active ingredient
- Roflumilast
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 500mg
Daliresp details
- Alternative names
- Daxas
- Therapeutic class
- Phosphodiesterase-4 Inhibitor
- Pharmacological class
- PDE4 Inhibitor
- Minor side effects
- diarrhoea; nausea; weight loss; abdominal pain
- Moderate side effects
- headache; insomnia; anxiety
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- AstraZeneca
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature in a dry place.
- Drug interactions
- rifampicin; phenobarbital; carbamazepine; phenytoin
- Age restrictions
- Not for use in those under 18 years.
- Pregnancy and breastfeeding
- Pregnancy: Avoid. Breastfeeding: Avoid.
Contraindications
hypersensitivity; moderate to severe hepatic impairment; severe immunological diseases; severe acute infectious diseases
Precautions and warnings
monitor weight regularly; use with caution in history of depression; discontinue if suicidal ideation occurs
Serious side effects
suicidal ideation, requires immediate medical attention; severe depression, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
Product intended to target chronic obstructive pulmonary disease and formulated to alleviate respiratory inflammation.
Mechanism of action
This medicine inhibits phosphodiesterase-4, an enzyme involved in inflammatory processes, reducing inflammation in the airways to improve breathing in chronic respiratory conditions.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Daliresp
Daliresp contains Roflumilast, a medication used to reduce the risk of exacerbations in patients with Chronic Obstructive Pulmonary Disease. The same active ingredient is also sold under the brand name Daxas. Manufactured by AstraZeneca, Daliresp is supplied as a tablet in a strength of 500mg.
Buying Daliresp online
Daliresp is registered across 13 markets including Hong Kong, Thailand and Malaysia, with availability also in the Philippines, Indonesia and Taiwan. Generic Roflumilast, much of it made in India, is often more affordable than the original brand. As one of the most ordered medications for respiratory support in the region, patients and expats often choose to order online for delivery to these and other locations.